Discovery of 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione as a dual inhibitor of the Raf/MEK/ERK and the PI3K/Akt signaling pathways

被引：35
|
作者：
Li, Qianbin [1 ]
Wu, Jingde [1 ]
Zheng, Hui [2 ]
Liu, Kai [1 ]
Guo, Tai L. [3 ]
Liu, Yuying [2 ]
Eblen, Scott T. [2 ]
Grant, Steven [4 ]
Zhang, Shijun [1 ]
机构：
[1] Virginia Commonwealth Univ, Dept Med Chem, Sch Pharm, Richmond, VA 23298 USA
[2] Med Univ S Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA
[3] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
[4] Virginia Commonwealth Univ, Dept Internal Med & Biochem, Richmond, VA 23298 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2010年 / 20卷 / 15期
关键词：
Dual pathway inhibitor; Raf/MEK/ERK; PI3K/Akt; Thiazolidine-2,4-dione; PROTEIN-KINASE PATHWAY; HUMAN LEUKEMIA-CELLS; PROSTATE-CANCER; MOUSE MODEL; INVOLVEMENT; APOPTOSIS; 3-KINASE; GROWTH; RAS;
D O I：
10.1016/j.bmcl.2010.06.030
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A thiazolidine-2,4-dione derivative, 3-(2-aminoethyl)-5-(3-phenyl-propylidene)-thiazolidine-2,4-dione (2), was identified as a dual inhibitor of the Raf/MEK/ extracellular signal-regulated kinase (ERK) and the phosphatidylinositol 3-kinase (PI3K)/Akt signaling cascades. The discovered compound inhibited cell proliferation, induced early apoptosis, and arrested cells in G(0)/G(1) phase in human leukemia U937 cells. These results indicate its potential as a new lead compound to develop novel dual signaling pathway inhibitors and anticancer agents. Published by Elsevier Ltd.
引用
收藏
页码：4526 / 4530
页数：5
相关论文
共 50 条
  • [41] Synthesis and antimicrobial activity of novel 5-[(1H-indol-3-yl)methylene]thiazolidine-2,4-dione–[1,2,3]triazole hybrids
    L. Kamala
    B. S. Veena
    P. V. Anantha Lakshmi
    P. Vasantha
    E. Sujatha
    Russian Journal of General Chemistry, 2017, 87 : 316 - 321
  • [42] Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways
    Zhang, Ya-Jun
    Xu, Zhi-Gang
    Li, Shi-Qiang
    He, Liu-Jun
    Tang, Yan
    Chen, Zhong-Zhu
    Yang, Dong-Lin
    CANCER CELL INTERNATIONAL, 2018, 18
  • [43] Key roles of the RAF/MEK/ERK and PI3K/Akt signal transduction pathways in drug resistance and the prevention of apoptosis in myeloid cells
    McCubrey, J.
    Abrams, S.
    Steelman, L.
    Wong, E.
    Chappell, W.
    Basecke, J.
    Stivala, F.
    Libra, M.
    ANNALS OF HEMATOLOGY, 2006, 85 : 16 - 16
  • [44] Roles of Raf/MEK/ERK and PI3K/Akt/mTOR pathways in prevention of apoptosis and induction of drug resistance in myeloid hematopoietic cells
    Abrams, Steve L.
    Evangelisti, Camilla
    Chiarini, Francesca
    Misaghian, Negin
    Basecke, Jorg
    Millela, Michelle
    Tafuri, Agostino
    Libra, Massimo
    Stivala, Franca
    Konopleva, Marina
    Andreeff, Michael
    Steelman, Linda S.
    Troppmair, Jacob
    Martelli, Alberto M.
    McCubrey, James. A.
    BLOOD, 2007, 110 (11) : 197A - 198A
  • [45] Benzimidazoisoquinoline derivatives inhibit glioblastoma cell proliferation through down-regulating Raf/MEK/ERK and PI3K/AKT pathways
    Ya-Jun Zhang
    Zhi-Gang Xu
    Shi-Qiang Li
    Liu-Jun He
    Yan Tang
    Zhong-Zhu Chen
    Dong-Lin Yang
    Cancer Cell International, 18
  • [46] Molecular docking of (5E)-3-(2-aminoethyl)-5-(2-thienylmethylene)-1, 3-thiazolidine-2, 4-dione on HIV-1 reverse transcriptase: novel drug acting on enzyme
    Seniya, Chandrabhan
    Yadav, Ajay
    Uchadia, Kuldeep
    Kumar, Sanjay
    Sagar, Nitin
    Shrivastava, Priyanka
    Shrivastava, Shilpi
    Wadhwa, Gulshan
    BIOINFORMATION, 2012, 8 (14) : 678 - 683
  • [47] Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments
    Ciuffreda, Ludovica
    McCubrey, James A.
    Milella, Michele
    CURRENT SIGNAL TRANSDUCTION THERAPY, 2009, 4 (02) : 130 - 143
  • [48] Dequalinium induces cytotoxicity in human leukemia NB4 cells by downregulation of Raf/MEK/ERK and PI3K/Akt signaling pathways and potentiation of specific inhibitors of these pathways
    Garcia-Perez, Ana I.
    Galeano, Eva
    Nieto, Elena
    Cristina Estan, M.
    Sancho, Pilar
    LEUKEMIA RESEARCH, 2014, 38 (07) : 795 - 803
  • [49] MicroRNA-195 targets VEGFR2 and has a tumor suppressive role in ACHN cells via PI3K/Akt and Raf/MEK/ERK signaling pathways
    Sun, Pengcheng
    Wang, Lu
    Lu, Yunhan
    Liu, Yuwei
    Li, Lechen
    Yin, Luyao
    Zhang, Cheng
    Zhao, Weiming
    Shen, Baozhong
    Xu, Wanhai
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 49 (03) : 1155 - 1163
  • [50] Tanshinone IIA can inhibit MiaPaCa-2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways
    Su, Chin-Cheng
    ONCOLOGY REPORTS, 2018, 40 (05) : 3102 - 3111
12345